{Reference Type}: Journal Article
{Title}: Unveiling the genetic tapestry: Rare disease genomics of spinal muscular atrophy and phenylketonuria proteins.
{Author}: Nawn D;Hassan SS;Redwan EM;Bhattacharya T;Basu P;Lundstrom K;Uversky VN;
{Journal}: Int J Biol Macromol
{Volume}: 269
{Issue}: 0
{Year}: 2024 Jun 1
{Factor}: 8.025
{DOI}: 10.1016/j.ijbiomac.2024.131960
{Abstract}: Rare diseases, defined by their low prevalence, present significant challenges, including delayed detection, expensive treatments, and limited research. This study delves into the genetic basis of two noteworthy rare diseases in Saudi Arabia: Phenylketonuria (PKU) and Spinal Muscular Atrophy (SMA). PKU, resulting from mutations in the phenylalanine hydroxylase (PAH) gene, exhibits geographical variability and impacts intellectual abilities. SMA, characterized by motor neuron loss, is linked to mutations in the survival of motor neuron 1 (SMN1) gene. Recognizing the importance of unveiling signature genomics in rare diseases, we conducted a quantitative study on PAH and SMN1 proteins of multiple organisms by employing various quantitative techniques to assess genetic variations. The derived signature-genomics contributes to a deeper understanding of these critical genes, paving the way for enhanced diagnostics for disorders associated with PAH and SMN1.